Thomas A. Shea Joins EPIRUS Biopharmaceuticals as Chief Financial Officer EPIRUS Biopharmaceuticals, Inc. , a privately held biotechnology company focused on the development and production of biosimilar products in and for major emerging markets,
June 18, 2013 - Business Wire via Yahoo! Finance